BBNX - Beta Bionics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Beta Bionics, Inc. Common Stock
IPO Date: January 30, 2025
Sector: Healthcare
Industry: Medical Devices
Market Cap: $1.15B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.66 | 3.89%
Avg Daily Range (30 D): $0.74 | 4.11%
Avg Daily Range (90 D): $0.59 | 3.87%
Institutional Daily Volume
Avg Daily Volume: .74M
Avg Daily Volume (30 D): 1.13M
Avg Daily Volume (90 D): .97M
Trade Size
Avg Trade Size (Sh.): 73
Avg Trade Size (Sh.) (30 D): 79
Avg Trade Size (Sh.) (90 D): 74
Institutional Trades
Total Institutional Trades: 600
Avg Institutional Trade: $2.42M
Avg Institutional Trade (30 D): $2.65M
Avg Institutional Trade (90 D): $2.34M
Avg Institutional Trade Volume: .13M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.52M
Avg Closing Trade (30 D): $2.96M
Avg Closing Trade (90 D): $2.45M
Avg Closing Volume: 143.5K
 
News
Sep 16, 2026 @ 10:00 PM
BBNX INVESTORS: Contact Kirby McInerney LLP About ...
Source: Kirby Mcinerney Llp
Sep 16, 2026 @ 3:56 AM
Beta Bionics Announces Pricing of Public Offering ...
Source: Not Specified
Sep 16, 2026 @ 12:03 AM
SHAREHOLDER ALERT: Beta Bionics, Inc. Sued for Sec...
Source: Block & Leviton Llp
Sep 15, 2026 @ 5:56 PM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta B...
Source: Rosen Law Firm
Sep 11, 2026 @ 12:29 AM
Beta Bionics (NASDAQ: BBNX) Faces Securities Class...
Source: Hagens Berman
Financials
  TTM Q1 2026 Q3 2025
Basic EPS $-.53 $-.49 $-.33
Diluted EPS $-.53 $-.49 $-.33
Revenue $32.01M $27.63M $27.25M
Gross Profit $18.9M $16.44M $15.12M
Net Income / Loss $-23.4M $-21.9M $-14.21M
Operating Income / Loss $-25.58M $-24.27M $-17.04M
Cost of Revenue $13.11M $11.19M $12.13M
Net Cash Flow $14.11M $-1.37M $3.41M
PE Ratio